573
Views
31
CrossRef citations to date
0
Altmetric
Original ArticleS: Clinical

Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen

, , , , , , , , , , , , , , , & show all
Pages 387-393 | Received 27 Jun 2010, Accepted 19 Oct 2010, Published online: 06 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Piotr Smolewski, Dominika Rydygier & Tadeusz Robak. (2019) Clinical management of mantle cell lymphoma in the elderly. Expert Opinion on Pharmacotherapy 20:15, pages 1893-1905.
Read now
Nishanth Vallumsetla, Jonas Paludo & Prashant Kapoor. (2015) Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes. Therapeutics and Clinical Risk Management 11, pages 1663-1674.
Read now
Martin Dreyling, Aaron Polliack & Tamar Tadmor. (2011) Chlorambucil in indolent mantle cell lymphoma – just another old drug for a new disease?. Leukemia & Lymphoma 52:3, pages 351-352.
Read now

Articles from other publishers (28)

Toby A. Eyre, Mark J. Bishton, Rory McCulloch, Maeve O'Reilly, Robin Sanderson, Geetha Menon, Sunil Iyengar, David Lewis, Jonathan Lambert, Kim M. Linton & Pamela McKay. (2023) Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology.
Crossref
Tahera Alnassfan, Megan J. Cox‐Pridmore, Azzam Taktak & Kathleen J Till. (2021) Mantle cell lymphoma treatment options for elderly/unfit patients: A systematic review. eJHaem 3:1, pages 276-290.
Crossref
Jessalyn A. Weaver, Yi Peng, Yuanyuan Ji, David Gilbertson, Daniel F. Pease & Vicki A. Morrison. (2021) A medicare database analysis of practice patterns in patients with mantle cell lymphoma. Journal of Geriatric Oncology 12:6, pages 894-901.
Crossref
Akriti Gupta Jain, Chung-Che Chang, Sarfraz Ahmad & Shahram Mori. (2019) Leukemic Non-nodal Mantle Cell Lymphoma: Diagnosis and Treatment. Current Treatment Options in Oncology 20:12.
Crossref
Pamela McKay, Mike Leach, Bob Jackson, Stephen Robinson & Simon Rule. (2018) Guideline for the management of mantle cell lymphoma. British Journal of Haematology 182:1, pages 46-62.
Crossref
Daniel F. Pease & Vicki A. Morrison. (2018) Treatment of mantle cell lymphoma in older adults. Journal of Geriatric Oncology 9:4, pages 308-314.
Crossref
C. Buske, M. Hutchings, M. Ladetto, V. Goede, U. Mey, P. Soubeyran, M. Spina, R. Stauder, M. Trněný, U. Wedding, P. Fields, Christian Buske, Martin Dreyling, Andrés J M Ferreri, Paul Fields, Gianluca Gaidano, Valentin Goede, Martin Hutchings, Marco Ladetto, Steven Le Gouill, Stefano Luminari, Ulrich Mey, Peter de Nully Brown, Michael Pfreundschuh, Christiane Pott, Norbert Schmitz, Pierre Soubeyran, Michele Spina, Reinhard Stauder, Anna Sureda Balari, Marek Trněný, Gustaaf van Imhoff, Jan Walewski, Ulrich Wedding, Alberto Zamò & Emanuele Zucca. (2018) ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma. Annals of Oncology 29:3, pages 544-562.
Crossref
Gabriele Reinartz, Tobias Weiglein, Kai Kröger & Martin Dreyling. 2017. Radiation Oncology. Radiation Oncology 1 14 .
Pierre Soubeyran & Rémy Gressin. (2016) Treatment of the elderly patient with mantle cell lymphoma. Hematology 2016:1, pages 425-431.
Crossref
Arati A. Inamdar, Andre Goy, Nehad M. Ayoub, Christen Attia, Lucia Oton, Varun Taruvai, Mark Costales, Yu-Ting Lin, Andrew Pecora & K. Stephen Suh. (2016) Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents. Oncotarget 7:30, pages 48692-48731.
Crossref
Moniba Nazeef & Brad S. Kahl. (2015) Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation. Current Treatment Options in Oncology 16:6.
Crossref
Elias Campo & Simon Rule. (2015) Mantle cell lymphoma: evolving management strategies. Blood 125:1, pages 48-55.
Crossref
M Dreyling, S Ferrero & O Hermine. (2014) How to manage mantle cell lymphoma. Leukemia 28:11, pages 2117-2130.
Crossref
M. Dreyling, C. Geisler, O. Hermine, H.C. Kluin-Nelemans, S. Le Gouill, S. Rule, O. Shpilberg, J. Walewski & M. Ladetto. (2014) Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 25, pages iii83-iii92.
Crossref
H. Gill, W.Y. Au, W.W. Cheung, E.Y. Lee & Y.L. Kwong. (2014) Oral arsenic trioxide-based regimen as salvage treatment for relapsed or refractory mantle cell lymphoma. Annals of Oncology 25:7, pages 1391-1397.
Crossref
Alexander Kanellopoulos, Katrina Koutsi, George Georgiou, Themis Ntalagiorgos, Kyriaki Petevi, George Boutsikas, Loula Papageorgiou, Gabriela Gainaru, Pagona Flevari, Maria K. Angelopoulou, John Meletis & Theodoros P. Vassilakopoulos. (2014) Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma. International Journal of Hematology 99:6, pages 777-781.
Crossref
Engin Kelkitli, Hilmi Atay, Levent Yıldız, Ahmet Bektaş & Mehmet Turgut. (2014) Mantle Cell Lymphoma Mimicking Rectal Carcinoma. Case Reports in Hematology 2014, pages 1-4.
Crossref
Catherine M. Clavel, Emilia Păunescu, Patrycja Nowak-Sliwinska & Paul J. Dyson. (2014) Thermoresponsive organometallic arene ruthenium complexes for tumour targeting. Chemical Science 5:3, pages 1097.
Crossref
Dolores Caballero, Elías Campo, Armando López-Guillermo, Alejandro Martín, Reyes Arranz-Sáez, Eva Giné, Andrés López, Eva González-Barca, Miguel Ángel Canales, Marcos González-Díaz & Alberto Orfao. (2013) Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group. Annals of Hematology 92:9, pages 1151-1179.
Crossref
M. Dreyling, C. Thieblemont, A. Gallamini, L. Arcaini, E. Campo, O. Hermine, J.C. Kluin-Nelemans, M. Ladetto, S. Le Gouill, E. Iannitto, S. Pileri, J. Rodriguez, N. Schmitz, A. Wotherspoon, P. Zinzani & E. Zucca. (2013) ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Annals of Oncology 24:4, pages 857-877.
Crossref
Jan Walewski. (2013) Chłoniak z komórek płaszcza u pacjentów niekwalifikujących się do chemioterapii w wysokich dawkach. Acta Haematologica Polonica 44:2, pages 104-109.
Crossref
Christina KalpadakisGerassimos A. PangalisMaria K. AngelopoulouSotirios SachanasFlora N. KontopidouXanthi YiakoumisStella I. KokorisEvagelia M. DimitriadouMaria N. DimopoulouMaria MoschogiannisPenelope KorkolopoulouMarie-Christine KyrtsonisMarina P. SiakantarisTheodora Papadaki, Panayiotis TsaftaridisEleni PlataHelen E. PapadakiTheodoros P. Vassilakopoulos. (2013) Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy. The Oncologist 18:2, pages 190-197.
Crossref
P. McKay, M. Leach, R. Jackson, G. Cook & S. Rule. (2012) Guidelines for the investigation and management of mantle cell lymphoma. British Journal of Haematology 159:4, pages 405-426.
Crossref
Pankaj GuptaDavid M. GoldenbergEdmund A. RossiThomas M. CardilloJohn C. Byrd, Natarajan Muthusamy, Richard R. Furman & Chien-Hsing Chang. (2012) Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas. Blood 119:16, pages 3767-3778.
Crossref
Marco Gunnellini & Lorenzo Falchi. (2012) Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin’s Lymphomas. Advances in Hematology 2012, pages 1-7.
Crossref
Catherine M. Clavel, Olivier Zava, Frédéric Schmitt, Blanka Halamoda Kenzaoui, Alexey A. Nazarov, Lucienne Juillerat-Jeanneret & Paul J. Dyson. (2011) Thermoresponsive Chlorambucil Derivatives for Tumour Targeting. Angewandte Chemie International Edition 50:31, pages 7124-7127.
Crossref
Catherine M. Clavel, Olivier Zava, Frédéric Schmitt, Blanka Halamoda Kenzaoui, Alexey A. Nazarov, Lucienne Juillerat‐Jeanneret & Paul J. Dyson. (2011) Thermoresponsive Chlorambucil Derivatives for Tumour Targeting. Angewandte Chemie 123:31, pages 7262-7265.
Crossref
Stéphanie Harel, Richard Delarue, Vincent Ribrag, Martin Dreyling & Olivier Hermine. (2011) Treatment of Younger Patients With Mantle Cell Lymphoma. Seminars in Hematology 48:3, pages 194-207.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.